Mark Kris, MD: Choosing a Treatment in NSCLC
How to Select Treatment for Resectable Stage III Lung CancerПодробнее
Dr. Mark Kris on Immunotherapy and Frontline Options for Patients With NSCLCПодробнее
Mark Kris, MD: Antiangiogenic Therapy in NSCLCПодробнее
Mark Kris, MD: Lacking Actionable Mutations in NSCLCПодробнее
Mark Kris on New Therapies for Lung CancerПодробнее
Choosing a lung cancer treatment facility videoПодробнее
Transforming Cancer Care with Cognitive Solutions: MSK-IBM Watson Oncology by Mark Kris, MDПодробнее